Talsaclidine, a novel M1-receptor selective muscarinic agonist for cholinergic substitution therapy of Alzheimer's disease. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with
Molecular Spectra
No Data Available
Click here to submit data
References
• 1 (1)
• Moreau, M., et al.: J. Pharmacol. Sci., 99, 6 (1)